HealthLinx | GenomeWeb

HealthLinx

Vermillion said this week that at its annual meeting on March 21, shareholders elected Robert Goggin to the company's board of directors.

John Evans has resigned as a non-executive director of Healthlinx due to increasing work commitments elsewhere. In his place, the company has appointed Malcolm Lucas-Smith.

Australian diagnostics firm Healthlinx said last week that its deal to sell intellectual property related to its OvPlex ovarian cancer diagnostic to San Diego-based start-up Mane Cancer Diagnostics has expired.

Mane Cancer Diagnostics has requested an extension of deadlines related to its acquisition of Healthlinx's OvPlex ovarian cancer test.
The request was noted in an address to investors last month by Healthlinx chairman Gregory Rice.

This article has been updated from a version posted Oct. 12 to include additional information.

Shareholders of Australian diagnostics firm Healthlinx voted last week to approve the sale of assets related to the company's ovarian cancer test, OvPlex.

Australian diagnostics firm HealthLinx said that preliminary data from a Korean Food and Drug Administration study of its ovarian cancer diagnostic OvPlex showed that the test offers an advantage over use of CA125 alone – currently the standard biomarker test used in ovarian canc

Provista Diagnostics has formed its scientific advisory board, appointing Karen Anderson, Carlos Arteaga, Robert Benezra, Andrew Dannenberg, and Joshua LaBaer.

Ezose Sciences this week named Scott Siegel its chief operating officer, a newly created position at the company.

NEW YORK (GenomeWeb News) – Australian biomarker-based diagnostic firm Healthlinx today announced a distribution deal to begin offering its OvPlex test in India in the third quarter.

Pages

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.